The central reninangiotensin system is important in the control of blood pressure in the adult. However, few data exist about the in utero development of central angiotensin-mediated pressor responses. Our recent studies have shown that the application of ANG II into the fetal brain can increase blood pressure at near term. The present study determined fetal blood pressure and heart rate in response to a central application of ANG II in the chronically prepared preterm ovine fetus, determined the action sites marked by c-Fos expression in the fetal central pathways after intracerebroventricular injection of ANG II in utero, and determined angiotensin subtype 1 receptors in the fetal hypothalamus. Central injection of ANG II significantly increased fetal mean arterial pressure (MAP). Adjusted fetal MAP against amniotic pressure was also increased by ANG II. Fetal heart rate was subsequently decreased after the central administration of ANG II and/or the increase of blood pressure. ANG II induced c-Fos expression in the central putative cardiovascular area, the paraventricular nuclei in the brain sympathetic pathway. Application of ANG II also caused intense Fos immunoreactivity in the tractus solitarius nuclei in the hindbrain. In addition, intense angiotensin subtype 1 receptors were expressed in the hypothalamus at preterm. These data demonstrate that central ANG II-related pressor centers start to function as early as at preterm and suggest that the central angiotensin-related sympathetic pathway is likely intact in the control of blood pressure in utero.in utero pressor; angiotensin type 1 receptor; developmental brain pathway ANGIOTENSIN II (ANG II) is a potent vasoconstrictive hormone, and a number of studies have demonstrated the importance of the renin-angiotensin system (RAS) in the control of blood pressure (BP) (1,19,23). Earlier work has shown that an active RAS is present in the ovine fetus before birth (6, 15). Its major function appears to be the regulation of fetal arterial pressure under conditions of fetal stress, including acute hemorrhage or hypoxia (17). However, study of the development of the central RAS in the regulation of BP in utero is still limited. Notably, most previous work performed in the fetus focused exclusively on actions of angiotensin at the peripheral side in the control of BP in utero (8,10,15,17,28). Our recent studies have demonstrated an increase of fetal mean arterial pressure (MAP) immediately after an injection of ANG II into the lateral ventricle of the near-term (90% gestational age) ovine fetal brain in utero (36). This observation prompted initial experiments investigating the cardiovascular action of fetal intracerebroventricular injection of octapeptide ANG II.In the adult, administration of either ANG II or its precursors into the brain induces pressor responses, drinking, and release of hormones (3,11,29). A number of studies have confirmed that almost all biological effects of ANG II are expressed via angiotensin subtype 1 (AT 1 ) receptors, not AT 2 receptor...